• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
.Analysis of one case of Yangxinshi Tablets combined with Western medicine standardization treatment on patients with recurrent heart failure after PCI[J].Journal Of Pharmaceutical Research,2020,39(11):676-679[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2870times   Download 2185次 QR Code for this article
Scan with your phone!
养心氏片联合西药标准化用药治疗PCI后反复心衰患者典型病例分析
范晓艳1,张振伟2,郭彩杰3
Font:Larger+|Default|Smaller-
(1.山东中医药大学附属医院,山东 济南 250011;2.济南市第三人民医院,山东 济南 250132;3.上海医药集团青岛国风药业股份有限公司,山东 青岛 266071)
摘要:
目的 探索联合养心氏片治疗PCI后反复心衰疗效。方法 对PCI术后反复心衰患者西进行医规范化治疗的基础上联合养心氏片治疗,观察患者的心率、血压、室性早搏、电解质和肾功能变化指标,运动耐量变化。结果 住院服药后患者的心率下降、血压正常、室性早搏减少、电解质和肾功能变化指标正常,运动耐量提升。结论 养心氏片治疗PCI后反复心衰患者能够改善患者临床症状,提高运动耐量,效果较好,值得临床推广应用。
关键词:  慢性心力衰竭  冠状动脉介入术后  养心氏片  运动耐量
DOI:10.13506/j.cnki.jpr.2020.11.013
基金项目:
Publication Date:November 25, 2020
Analysis of one case of Yangxinshi Tablets combined with Western medicine standardization treatment on patients with recurrent heart failure after PCI
()
Abstract:
Objective To explore the efficacy of Yangxinshi Tablets combined with western medicine standardization treatment on patients with recurrent heart failure after PCI.Methods On the basis of standardized medical treatment of western medicine,Yangxinshi Tablets were used to treat patients with the patients with recurrent heart failure after PCI, and observe the changes of the heart rate, blood pressure, premature ventricular contractions,electrolyte and renal function, exercise tolerance.Results After treatment, the patient's heart rate decreased, blood pressure was normal, ventricular premature beats decreased,electrolyte and renal function changes were normal, and exercise tolerance increased.Conclusion Yangxinshi Tablets can improve the clinical symptoms and improve the exercise tolerance of patients with repeated heart failure after PCI. It is worthy of clinical application.
Key words:  Chronic heart failure  After PCI  Yangxinshi Tables  Metabolic equivalent
Today's Visits:527    Total Visits:2383269
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.